应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09989 海普瑞
休市中 05-09 16:08:07
4.620
-0.020
-0.43%
最高
4.680
最低
4.560
成交量
103.90万
今开
4.680
昨收
4.640
日振幅
2.59%
总市值
67.79亿
流通市值
10.16亿
总股本
14.67亿
成交额
477.75万
换手率
0.47%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
深圳市海普瑞药业集团股份有限公司化学修饰的糖胺聚糖类衍生物的抗病毒用途专利公布(医学专利快讯)
iDoNews · 15:17
深圳市海普瑞药业集团股份有限公司化学修饰的糖胺聚糖类衍生物的抗病毒用途专利公布(医学专利快讯)
海普瑞05月09日主力净流出49.6万元 散户资金买入
市场透视 · 08:15
海普瑞05月09日主力净流出49.6万元 散户资金买入
海普瑞04月30日主力净流出43.5万元 散户资金买入
市场透视 · 04-30
海普瑞04月30日主力净流出43.5万元 散户资金买入
海普瑞04月25日主力净流出54万元 散户资金买入
市场透视 · 04-25
海普瑞04月25日主力净流出54万元 散户资金买入
图解海普瑞一季报:第一季度单季净利润同比增1.00%
证券之星 · 04-24
图解海普瑞一季报:第一季度单季净利润同比增1.00%
海普瑞(002399.SZ)发布一季度业绩,归母净利润1.57亿元,同比增长1.00%
智通财经 · 04-24
海普瑞(002399.SZ)发布一季度业绩,归母净利润1.57亿元,同比增长1.00%
海普瑞:IVENOXIN获得南非批准
格隆汇 · 04-24
海普瑞:IVENOXIN获得南非批准
海普瑞(09989):Ivenoxin获南非健康产品监管局上市许可
智通财经网 · 04-24
海普瑞(09989):Ivenoxin获南非健康产品监管局上市许可
海普瑞(09989)发布一季度业绩,归母净利润1.57亿元,同比增长1%
智通财经 · 04-24
海普瑞(09989)发布一季度业绩,归母净利润1.57亿元,同比增长1%
海普瑞:2025年第一季度净利润1.57亿元 同比增长1.00%
21世纪经济报道 · 04-24
海普瑞:2025年第一季度净利润1.57亿元 同比增长1.00%
海普瑞最新公告:依诺肝素钠注射液获得南非药品注册批件
证券之星 · 04-24
海普瑞最新公告:依诺肝素钠注射液获得南非药品注册批件
海普瑞04月16日主力净流出62万元 散户资金买入
市场透视 · 04-16
海普瑞04月16日主力净流出62万元 散户资金买入
海普瑞04月14日主力净流入45万元 散户资金抛售
市场透视 · 04-14
海普瑞04月14日主力净流入45万元 散户资金抛售
海普瑞03月11日主力净流出54万元 散户资金买入
市场透视 · 03-11
海普瑞03月11日主力净流出54万元 散户资金买入
海普瑞:公司始终坚持聚焦核心主业,提升公司内在价值
互动易 · 03-05
海普瑞:公司始终坚持聚焦核心主业,提升公司内在价值
海普瑞:公司将持续加强市值管理工作争取为股东带来更好回报
证券之星 · 03-05
海普瑞:公司将持续加强市值管理工作争取为股东带来更好回报
海普瑞:公司专注主业已建立全球销售网络和全肝素产业链领先优势
证券之星 · 03-05
海普瑞:公司专注主业已建立全球销售网络和全肝素产业链领先优势
海普瑞03月05日主力净流入69万元 散户资金抛售
市场透视 · 03-05
海普瑞03月05日主力净流入69万元 散户资金抛售
海普瑞收盘下跌3.16%,最新市净率1.37,总市值166.24亿元
金融界 · 02-28
海普瑞收盘下跌3.16%,最新市净率1.37,总市值166.24亿元
海普瑞:坚持深耕主业,巩固全球销售网络和全肝素产业链垂直打通的领先优势
互动易 · 02-27
海普瑞:坚持深耕主业,巩固全球销售网络和全肝素产业链垂直打通的领先优势
加载更多
公司概况
公司名称:
海普瑞
所属市场:
SEHK
上市日期:
--
主营业务:
深圳市海普瑞药业集团股份有限公司是一家中国制药公司,在肝素钠制剂及原料药领域、大分子药物合同开发和生产组织(CDMO)领域以及创新药开发领域拥有业务。该公司主要产品和服务包括依诺肝素钠制剂和肝素钠原料药、依诺肝素钠原料药,以及大分子药物CDMO服务。该公司的产品在国内市场和包括土耳其、巴西、美国等在内的海外市场销售。
发行价格:
--
{"stockData":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":4.62,"timestamp":1746778087022,"preClose":4.64,"halted":0,"volume":1039000,"delay":0,"floatShares":220000000,"shares":1467296204,"eps":0.4735991599318612,"marketStatus":"休市中","change":-0.02,"latestTime":"05-09 16:08:07","open":4.68,"high":4.68,"low":4.56,"amount":4777465,"amplitude":0.025862,"askPrice":4.62,"askSize":14000,"bidPrice":4.61,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":0.47463918712517794,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":7,"adr":0,"listingDate":1594137600000,"exchange":"SEHK","adjPreClose":4.64,"dividendRate":0.023333,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.653377,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":11,"timestamp":1746774000000,"preClose":11.08,"halted":0,"volume":2965200,"delay":0,"premium":"-60.91"}},"requestUrl":"/m/hq/s/09989","defaultTab":"news","newsList":[{"id":"2534434998","title":"深圳市海普瑞药业集团股份有限公司化学修饰的糖胺聚糖类衍生物的抗病毒用途专利公布(医学专利快讯)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534434998","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534434998?lang=zh_cn&edition=full","pubTime":"2025-05-09 23:17","pubTimestamp":1746803822,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年5月9日,“化学修饰的糖胺聚糖类衍生物的抗病毒用途”正式进入专利公布阶段。申请人为深圳市海普瑞药业集团股份有限公司,该项医学专利涉及抗病毒药物的研发与应用。此外,该化合物还具有显著优化的药代动力学性质,生物利用度高,半衰期长,可制备成缓释制剂或长效制剂,患者依从性良好。“本发明提供一种化学修饰的糖胺聚糖类衍生物或含所述糖胺聚糖衍生物的组合物在制备抗病毒药物中的用途。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505092319289754a61a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505092319289754a61a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989","BK1191"],"gpt_icon":0},{"id":"2534177846","title":"海普瑞05月09日主力净流出49.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2534177846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534177846?lang=zh_cn&edition=full","pubTime":"2025-05-09 16:15","pubTimestamp":1746778521,"startTime":"0","endTime":"0","summary":"05月09日, 海普瑞股价跌0.43%,报收4.62元,成交金额477.7万元,换手率0.47%,振幅2.59%,量比0.65。海普瑞今日主力资金净流出49.6万元,上一交易日主力净流入77.9万元。该股近5个交易日上涨3.60%,主力资金累计净流入260.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入401.9万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174807a477f88a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174807a477f88a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2531085737","title":"海普瑞04月30日主力净流出43.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531085737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531085737?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000927,"startTime":"0","endTime":"0","summary":"04月30日, 海普瑞股价跌0.89%,报收4.45元,成交金额231.3万元,换手率0.24%,振幅2.23%,量比0.42。海普瑞今日主力资金净流出43.5万元,上一交易日主力净流出0万元。该股近5个交易日上涨0.91%,主力资金累计净流出50.3万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出17.7万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170600a6ce993c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170600a6ce993c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989","BK1191"],"gpt_icon":0},{"id":"2530909325","title":"海普瑞04月25日主力净流出54万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2530909325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530909325?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:17","pubTimestamp":1745569049,"startTime":"0","endTime":"0","summary":"04月25日, 海普瑞股价跌1.13%,报收4.39元,成交金额691万元,换手率0.71%,振幅2.70%,量比1.84。海普瑞今日主力资金净流出54万元,上一交易日主力净流出0万元。该股近5个交易日上涨2.57%,主力资金累计净流入60万元;近20日主力资金累计净流出1万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171125a46694b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171125a46694b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2530660759","title":"图解海普瑞一季报:第一季度单季净利润同比增1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530660759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530660759?lang=zh_cn&edition=full","pubTime":"2025-04-25 02:10","pubTimestamp":1745518221,"startTime":"0","endTime":"0","summary":"证券之星消息,海普瑞2025年一季报显示,公司主营收入13.94亿元,同比上升1.53%;归母净利润1.57亿元,同比上升1.0%;扣非净利润1.89亿元,同比上升20.27%;负债率29.67%,投资收益2029.21万元,财务费用-5650.82万元,毛利率27.34%。财报数据概要请见下图:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425022458a465ba4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425022458a465ba4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989"],"gpt_icon":0},{"id":"2529960071","title":"海普瑞(002399.SZ)发布一季度业绩,归母净利润1.57亿元,同比增长1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529960071","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529960071?lang=zh_cn&edition=full","pubTime":"2025-04-24 19:22","pubTimestamp":1745493778,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞(002399.SZ)发布2025年一季度报告,第一季度,公司实现营业收入13.94亿元,同比增长1.53%。归属于上市公司股东的净利润1.57亿元,同比增长1.00%。归属于上市公司股东的扣除非经常性损益的净利润1.89亿元,同比增长20.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002399","09989"],"gpt_icon":0},{"id":"2529609676","title":"海普瑞:IVENOXIN获得南非批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2529609676","media":"格隆汇","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529609676?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:28","pubTimestamp":1745490535,"startTime":"0","endTime":"0","summary":"格隆汇4月24日丨海普瑞公告,公司全资子公司深圳市天道医药有限公司生产的依诺肝素钠注射液已获得南非健康产品监管局上市许可。此次获批意味着集团依诺肝素钠制剂可进入南非市场销售,进一步提升了集团依诺肝素钠制剂在全球的市场份额。董事会认为,这是集团制剂业务国际化布局的又一重要成果,再次印证了集团开拓海外市场的能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424182855a4653536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424182855a4653536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989","BK1191"],"gpt_icon":0},{"id":"2529604530","title":"海普瑞(09989):Ivenoxin获南非健康产品监管局上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2529604530","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529604530?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:24","pubTimestamp":1745490240,"startTime":"0","endTime":"0","summary":"海普瑞发布公告,公司全资子公司深圳市天道医药有限公司生产的依诺肝素钠注射液已获得南非健康产品监管局上市许可。此次获批意味着集团依诺肝素钠制剂可进入南非市场销售,进一步提升了集团依诺肝素钠制剂在全球的市场份额。董事会认为,这是集团制剂业务国际化布局的又一重要成果,再次印证了集团开拓海外市场的能力。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-24/doc-ineuhiqv2857399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","09989","BK1191","002399","BK0188","BK0070"],"gpt_icon":0},{"id":"2529606213","title":"海普瑞(09989)发布一季度业绩,归母净利润1.57亿元,同比增长1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529606213","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529606213?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:23","pubTimestamp":1745490195,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞(09989)发布2025年第一季度业绩,营业收入13.94亿元,同比增长1.53%;归属于上市公司股东的净利润1.57亿元,同比增长1%;基本每股收益0.1067元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002399","09989"],"gpt_icon":0},{"id":"2529096776","title":"海普瑞:2025年第一季度净利润1.57亿元 同比增长1.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529096776","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529096776?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:18","pubTimestamp":1745489880,"startTime":"0","endTime":"0","summary":"南财智讯4月24日电,海普瑞发布2025年第一季度报告,报告期实现营业收入13.94亿元,同比增长1.53%;归属上市公司股东的净利润1.57亿元,同比增长1.00%;扣除非经常性损益后的归属于上市公司股东的净利润1.89亿元,同比增长20.27%;基本每股收益0.1067元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241819119743694e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241819119743694e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989"],"gpt_icon":0},{"id":"2529603247","title":"海普瑞最新公告:依诺肝素钠注射液获得南非药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2529603247","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529603247?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:01","pubTimestamp":1745488878,"startTime":"0","endTime":"0","summary":"海普瑞公告称,全资孙公司天道医药收到南非卫生产品管理局签发的依诺肝素钠注射液批准通知。许可有效期为五年。本次获批将进一步提升公司依诺肝素钠制剂在全球的市场占有率,是公司制剂业务国际化布局的重要成果。截至公告日,该产品已在全球超过50个国家及地区获批上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400030864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","BK0239","09989","BK1191","BK0188","BK0070"],"gpt_icon":0},{"id":"2527298966","title":"海普瑞04月16日主力净流出62万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527298966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527298966?lang=zh_cn&edition=full","pubTime":"2025-04-16 16:16","pubTimestamp":1744791383,"startTime":"0","endTime":"0","summary":"04月16日, 海普瑞股价跌1.83%,报收4.28元,成交金额387万元,换手率0.41%,振幅2.98%,量比0.55。海普瑞今日主力资金净流出62万元,上一交易日主力净流出0万元。该股近5个交易日上涨2.40%,主力资金累计净流入27万元;近20日主力资金累计净流出266万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416173753a45aeb30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416173753a45aeb30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2527134515","title":"海普瑞04月14日主力净流入45万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2527134515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527134515?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:16","pubTimestamp":1744618597,"startTime":"0","endTime":"0","summary":"04月14日, 海普瑞股价涨2.30%,报收4.44元,成交金额902万元,换手率0.93%,振幅2.30%,量比0.56。海普瑞今日主力资金净流入45万元,上一交易日主力净流出0万元。该股近5个交易日上涨9.65%,主力资金累计净流入139万元;近20日主力资金累计净流出194万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171216a4584bc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414171216a4584bc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2518779763","title":"海普瑞03月11日主力净流出54万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518779763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518779763?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:15","pubTimestamp":1741680932,"startTime":"0","endTime":"0","summary":"03月11日, 海普瑞股价跌1.34%,报收4.43元,成交金额1610万元,换手率1.66%,振幅3.12%,量比1.40。海普瑞今日主力资金净流出54万元,上一交易日主力净流出0万元。该股近5个交易日下跌0.90%,主力资金累计净流入16万元;近20日主力资金累计净流入641万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165433abf60725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165433abf60725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2517911235","title":"海普瑞:公司始终坚持聚焦核心主业,提升公司内在价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2517911235","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517911235?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:54","pubTimestamp":1741179296,"startTime":"0","endTime":"0","summary":"有投资者向海普瑞提问, 工资如何维护投资者的利益?是否看好公司未来前景?能否推行员工持股股计划四期,能否回购公司股份注销?能否推动高管增持股份计划?能否2024年度分红扩股?公司回答表示,您好,公司始终坚持聚焦核心主业,提升公司内在价值,我们将持续加强市值管理工作,促进公司投资价值合理反映公司质量,争取为股东带来更好的回报。谢谢您的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305210621a260acf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305210621a260acf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2517193729","title":"海普瑞:公司将持续加强市值管理工作争取为股东带来更好回报","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517193729?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:51","pubTimestamp":1741179096,"startTime":"0","endTime":"0","summary":"证券之星消息,海普瑞(002399)03月04日在投资者关系平台上答复投资者关心的问题。投资者提问:工资如何维护投资者的利益?是否看好公司未来前景?能否推行员工持股股计划四期,能否回购公司股份注销?能否推动高管增持股份计划?能否2024年度分红扩股?海普瑞回复:您好,公司始终坚持聚焦核心主业,提升公司内在价值,我们将持续加强市值管理工作,促进公司投资价值合理反映公司质量,争取为股东带来更好的回报。谢谢您的关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500038393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK0070","002399","BK0188","09989"],"gpt_icon":0},{"id":"2517195619","title":"海普瑞:公司专注主业已建立全球销售网络和全肝素产业链领先优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2517195619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517195619?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:51","pubTimestamp":1741179092,"startTime":"0","endTime":"0","summary":"证券之星消息,海普瑞03月04日在投资者关系平台上答复投资者关心的问题。公司是否会进行投资?海普瑞回复:您好,公司专注主业,在肝素领域,我们已建立全球销售网络和全肝素产业链垂直打通的领先优势,核心产品依诺肝素钠制剂远销逾40个国家及地区。同时,我们持续探索合适机遇,如建立并推进与正大天晴、永太药业的商业合作,助力中国药企出海。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500038389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","BK0070","002399","BK1191","BK0188","BK0239"],"gpt_icon":0},{"id":"2517285995","title":"海普瑞03月05日主力净流入69万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517285995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517285995?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:15","pubTimestamp":1741162558,"startTime":"0","endTime":"0","summary":"03月05日, 海普瑞股价涨0.45%,报收4.48元,成交金额1224万元,换手率1.25%,振幅2.69%,量比0.80。海普瑞今日主力资金净流入69万元,上一交易日主力净流出0万元。该股近5个交易日下跌0.44%,主力资金累计净流入31万元;近20日主力资金累计净流入702万元,其中净流入天数为9日。该股主力净额占比0.07%,港股市场排名134/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170050a2605978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170050a2605978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0},{"id":"2514104103","title":"海普瑞收盘下跌3.16%,最新市净率1.37,总市值166.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514104103","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514104103?lang=zh_cn&edition=full","pubTime":"2025-02-28 16:56","pubTimestamp":1740733000,"startTime":"0","endTime":"0","summary":"2月28日,海普瑞今日收盘11.33元,下跌3.16%,最新市净率1.37,总市值166.24亿元。消息面上,海普瑞4月23日接待线上参与公司2023年年度业绩说明会的全体投资者等1家机构调研,上市公司接待人员包括董事长李锂,董事、总经理单宇,独立董事易铭,财务总监陈娟,董事会秘书钱风奇。最新一期业绩显示,2024年三季报,公司实现营业收入40.69亿元,同比0.14%;净利润7.80亿元,同比444.89%,销售毛利率33.20%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/28165648456446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0070","002399","09989","BK1191","BK0188","BK0239"],"gpt_icon":0},{"id":"2514680104","title":"海普瑞:坚持深耕主业,巩固全球销售网络和全肝素产业链垂直打通的领先优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680104","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514680104?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:51","pubTimestamp":1740660668,"startTime":"0","endTime":"0","summary":"有投资者向海普瑞提问, 你好,请问贵公司今年来基本没有在金融资本市场有什么动作是什么原因呢?是想直接躺平了吗?我看了下近年的公告,贵公司没有新增投资,没有重组计划和预期,没有回购或增持公司股票计划或者行动,没有资本运作,投资设立新公司都没有,请问这是为什么?公司回答表示,您好,公司坚持深耕主业,巩固全球销售网络和全肝素产业链垂直打通的领先优势,加大市场拓展力度,不断提高经营水平和发展质量,并努力提升股东回报水平。同时,我们持续探索合适机遇,如建立并推进与正大天晴、永太药业的商业合作。谢谢您的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227205515abdf54e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227205515abdf54e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0359},{"period":"1month","weight":0.1106},{"period":"3month","weight":0.1816},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.3509},{"period":"ytd","weight":0.1667}],"compareEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.1285},{"period":"3month","weight":0.0821},{"period":"6month","weight":0.1032},{"period":"1year","weight":0.2336},{"period":"ytd","weight":0.14}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海普瑞药业集团股份有限公司是一家中国制药公司,在肝素钠制剂及原料药领域、大分子药物合同开发和生产组织(CDMO)领域以及创新药开发领域拥有业务。该公司主要产品和服务包括依诺肝素钠制剂和肝素钠原料药、依诺肝素钠原料药,以及大分子药物CDMO服务。该公司的产品在国内市场和包括土耳其、巴西、美国等在内的海外市场销售。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.077941},{"month":2,"riseRate":0.6,"avgChangeRate":0.062513},{"month":3,"riseRate":0.2,"avgChangeRate":-0.064338},{"month":4,"riseRate":0.6,"avgChangeRate":0.032572},{"month":5,"riseRate":0.8,"avgChangeRate":0.005378},{"month":6,"riseRate":0.25,"avgChangeRate":0.004312},{"month":7,"riseRate":0.25,"avgChangeRate":-0.027387},{"month":8,"riseRate":0.2,"avgChangeRate":-0.024713},{"month":9,"riseRate":0.2,"avgChangeRate":-0.040162},{"month":10,"riseRate":0.4,"avgChangeRate":-0.029282},{"month":11,"riseRate":0.2,"avgChangeRate":-0.012257},{"month":12,"riseRate":0.2,"avgChangeRate":-0.020759}],"exchange":"SEHK","name":"海普瑞","nameEN":"HEPALINK"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,09989,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}